4 Best Genetic Sequencing Stocks for 2026 and How to Invest

Discover promising genetic sequencing stocks and stay ahead in the genomics revolution. Learn which companies are driving DNA technology forward.

Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know

Pacific Biosciences of California (PACB) concluded the recent trading session at $1.49, signifying a -4.49% move from its ...

Illumina: While You Chased AI, This Healthcare Stock Built A $30B Moat

Illumina dominates genomics sequencing with recurring growth, NovaSeq X catalysts, and improving margins/FCF. Click to know ...

Here's Why You Should Add PacBio Stock to Your Portfolio Now

PACB's growth is supported by HiFi sequencing advances and product momentum, though funding pressures weigh on instrument ...
Technology Networks

Deep Learning for Variant Calling: How DeepVariant and Neural Networks Are Improving Genomic Accuracy

Deep learning variant calling has transformed genomic accuracy. Discover how DeepVariant works, outperforms classical tools, ...

Cathie Wood's weekly recap: sells Tesla, AMD, HOOD, TER to fund SpaceX buying

Cathie Wood’s ARK Invest ETFs sharply repositioned portfolios during the last week, highlighted by a strong buildup in SpaceX (SPCX) as the markets poured funds, marking a blockbusterIPO. Cathie's Ark ...
New Haven Register

Pacific Biosciences: Q1 Earnings Snapshot

MENLO PARK, Calif. (AP) — MENLO PARK, Calif. (AP) — Pacific Biosciences of California Inc. (PACB) on Thursday reported a loss of $8.3 million in its first quarter. On a per-share basis, the Menlo Park ...
The Globe and Mail

PacBio Announces First Quarter 2026 Financial Results

MENLO PARK, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2026. “We continue to see increasing clinical adoption of ...